Negotiations restart for innovative breast cancer drug price

1 sourceFirst reported 2 hours agoUpdated 2 hours ago

AI summary: catch up in 20 seconds

The Committee for the Negotiation of Drug Prices is expected to convene within the next fortnight.
Representatives from Gilead Sciences will participate in the meeting.
The purpose of the meeting is to restart negotiations for the price of an innovative breast cancer drug.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Επανεκκίνηση των διαπραγματεύσεων για την τιμή καινοτόμου φαρμάκου για τον καρκίνο του μαστού -Η εκτιμώμενη δαπάνη του υπουργείου Υγείαςiefimerida.gr · 2 hours ago

AI summary: catch up in 20 seconds

The Committee for the Negotiation of Drug Prices is expected to convene within the next fortnight.
Representatives from Gilead Sciences will participate in the meeting.
The purpose of the meeting is to restart negotiations for the price of an innovative breast cancer drug.

Generated by AI from the 1 sources below · always verify with the originals

No comments yet. Be the first to join the discussion.